Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Circulating MOTS-c declines with age and tracks with insulin resistance, making it both a potential longevity biomarker and a therapeutic target
Hepatology 61, 337347
Start with your study goals, then match your dosage accordingly
The combination of improved blood pressure with a modest heart rate increase represents a net cardiovascular benefit for most individuals, but monitoring remains essential for those with pre-existing conditions
It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use
Supplied as a 10 mg lyophilized vial for reconstitution
US$ 25.42
US$ 28.15
US$ 28.14
US$ 28.63
US$ 25.06
US$ 24.61
US$ 22.18
US$ 28.38
US$ 25.43
US$ 21.27
US$ 23.69
US$ 21.82
US$ 20.25
